LOPAIN1 Trial
Chronic low back pain due to one or more degenerated lumbar discs
Safety/EfficacyActive
Key Facts
Indication
Chronic low back pain due to one or more degenerated lumbar discs
Phase
Safety/Efficacy
Status
Active
About Spinal Stabilization Technologies
Spinal Stabilization Technologies is a clinical-stage medical device company pioneering a novel, less invasive approach to treating discogenic low back pain through nucleus replacement. Its core technology, the PerQdisc™ system, is an in-situ formed silicone-based prosthesis designed to replace the diseased nucleus pulposus, emulate its natural biomechanics, and redistribute spinal loads. The company is currently advancing the PerQdisc through a series of clinical trials (N161, N181, LOPAIN, DISCPAIN1) to demonstrate safety and efficacy, with the device not yet approved for commercial sale in key markets like the US or CE-mark regions.
View full company profileTherapeutic Areas
Other Chronic low back pain due to one or more degenerated lumbar discs Drugs
| Drug | Company | Phase |
|---|---|---|
| LOPAIN2 Trial | Spinal Stabilization Technologies | Safety/Efficacy |